Chester County News and Community Website
PHILADELPHIA, PA — Proscia has become part of Agilent Technologies Inc. (NYSE: A) following the completion of a $240 million cash acquisition that expands Agilent’s digital pathology business and adds …
Proscia Joins Agilent in $240 Million Pathology Software Deal Read More PHILADELPHIA, PA — Proscia, a Philadelphia-based digital pathology software company serving more than 4,000 laboratories, hospitals and clinics, has agreed to be acquired by Agilent Technologies Inc. (NYSE: A) for …
Proscia to Join Agilent in Deal Worth Up to $270 Million Read More PHILADELPHIA, PA — Philadelphia-based digital pathology software company Proscia has agreed to be acquired by Agilent Technologies Inc. (NYSE: A) for up to $270 million, giving the scientific instruments maker …
Philadelphia’s Proscia to Sell to Agilent for Up to $270M Read More PHILADELPHIA, PA — Proscia is expanding the reach of its digital pathology technology across Unilabs’ European diagnostic network, with multiple countries already using the Philadelphia company’s Concentriq AP-Dx platform for …
Proscia Expands Digital Pathology Reach With Unilabs Read More PHILADELPHIA, PA — Proscia is expanding deployment of its digital pathology technology across Unilabs’ 12-country pathology network, giving the European diagnostics provider a common platform for routine case review, diagnostic …
Proscia Expands Digital Pathology Reach Across Unilabs Read More PHILADELPHIA, PA — Proscia received a new U.S. Food and Drug Administration 510(k) clearance for its Concentriq AP-Dx digital pathology platform, expanding scanner compatibility and giving the company a regulatory …
Proscia Expands FDA-Cleared Digital Pathology Platform Read More PHILADELPHIA, PA — Proscia received a new U.S. Food and Drug Administration 510(k) clearance for its Concentriq AP-Dx digital pathology platform, expanding scanner compatibility and giving the company a regulatory …
Proscia Wins FDA Clearance to Expand Digital Pathology Platform Read More PHILADELPHIA, PA — Proscia this week launched a major update to its Concentriq digital pathology platform, embedding new artificial intelligence capabilities aimed at helping diagnostic laboratories and pharmaceutical companies manage …
Proscia Rolls Out AI Platform Upgrade as Pathology Goes Digital Read More PHILADELPHIA, PA — Proscia has launched the fifth generation of its Concentriq digital pathology platform, introducing a new artificial intelligence architecture designed to automate workflow-intensive tasks for pathologists and drug …
Proscia Unveils AI Platform Overhaul as Pathology Digitizes Read More PHILADELPHIA, PA — NextGen Pathology has selected Proscia’s Concentriq digital pathology platform as part of a strategy to expand subspecialty diagnostic services and strengthen its position in the growing market …
NextGen Pathology Adopts AI Platform to Expand Services Read More